OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
04 Aprile 2024 - 2:05PM
OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:
KIDS), a company focused exclusively on advancing the field of
pediatric orthopedics, today announced it will attend the 8th
Annual International Children’s Spine Symposium (ICSS), which will
take place April 5th and 6th in Denver, Colorado. The meeting, put
on by the Armstrong Children’s Orthopedic Alliance, offers a
comprehensive program of lectures given by an outstanding,
international faculty and cadaver labs centered on the cervical
spine, lumbo-sacral junction, neuromonitoring, and various aspects
of scoliosis.
Over the course of the event, OrthoPediatrics
will highlight the unique benefits of its RESPONSE™ portfolio for
Scoliosis surgery, which offers an advanced system of instruments
and implants with enhanced versatility to aid in optimal patient
outcomes and allow surgeons to intervene at an earlier age and
treat smaller statures. Additionally, participants will have an
opportunity to see the new Rib and Pelvic Fixation system, launched
earlier this year for treating kids with Early Onset Scoliosis and
the ApiFix technology, a non-fusion alternative for patients with
Adolescent Idiopathic Scoliosis (“AIS”).
In addition to showcasing its product offering,
the Company has provided educational grants to hospitals and
institutions for their senior residents and fellows to attend the
course.
David Bailey, OrthoPediatrics’ President &
CEO, commented, “We are proud again to be the lead sponsor of ICSS,
a CME course we initiated eight years ago to advance our goal of
becoming a leading resource for continuing medical education in
pediatric orthopedics. We consider ICSS to be an interactive forum
that allows us to engage with pediatric orthopedic fellows and
attending surgeons and train on the latest technologies and
surgical techniques. The symposium is always well attended and
receives great feedback from attendees, so I am looking forward to
this being another productive event.”
About OrthoPediatrics
Corp.Founded in 2006, OrthoPediatrics is an orthopedic
company focused exclusively on advancing the field of pediatric
orthopedics. As such it has developed the most comprehensive
product offering to the pediatric orthopedic market to improve the
lives of children with orthopedic conditions. OrthoPediatrics
currently markets 71 products that serve three of the largest
categories within the pediatric orthopedic market. This product
offering spans trauma and deformity, scoliosis, and sports
medicine/other procedures. OrthoPediatrics’ global sales
organization is focused exclusively on pediatric orthopedics and
distributes its products in the United States and over 70 countries
outside the United States. For more information, please visit
www.orthopediatrics.com.
Investor ContactPhilip Trip
Taylor Gilmartin Groupphilip@gilmartinir.com415-937-5406
Grafico Azioni OrthoPediatrics (NASDAQ:KIDS)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni OrthoPediatrics (NASDAQ:KIDS)
Storico
Da Nov 2023 a Nov 2024